Trial
NCT03059849
Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
McMaster University
Collaborators
—
Condition
Crohn Disease
Intervention
Adalimumab
Why stopped
lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-01-18